Login / Signup

177Lu-PSMA-617 radioligand therapy in mCRPC: ready for phase III trial?

Kambiz RahbarHojjat AhmadzadehfarMartin Boegemann
Published in: European journal of nuclear medicine and molecular imaging (2017)
Keyphrases
  • phase iii
  • open label
  • clinical trial
  • pet ct
  • phase ii
  • double blind
  • placebo controlled
  • pet imaging
  • study protocol
  • bone marrow
  • mesenchymal stem cells
  • cell therapy